From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 3,208,292 shares, representing 3.11% for $19 million under the buyback announced on March 22, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.9 USD | -0.53% |
|
+9.31% | +0.54% |
05/06 | Catalyst Pharmaceuticals Insider Sold Shares Worth $276,735, According to a Recent SEC Filing | MT |
30/05 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.54% | 2.01B | |
+7.46% | 100B | |
+11.97% | 42.34B | |
-11.76% | 32.76B | |
+79.34% | 29.46B | |
-12.20% | 16.31B | |
+4.00% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B |
- Stock Market
- Equities
- CPRX Stock
- News Catalyst Pharmaceuticals, Inc.
- Tranche Update on Catalyst Pharmaceuticals, Inc.'s Equity Buyback Plan announced on March 22, 2021.